T 2623/18 (Hydrophilic filtration during manufacture of vaccine adjuvants/NOVARTIS) of 21.11.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T262318.20221121
- Date of decision
- 21 November 2022
- Case number
- T 2623/18
- Petition for review of
- -
- Application number
- 13157613.4
- IPC class
- A61K 39/12A61K 39/39A61K 9/107
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Hydrophilic filtration during manufacture of vaccine adjuvants
- Applicant name
- Seqirus UK Limited
- Opponent name
- SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES - SEPPIC
GlaxoSmithKline Biologicals S.A. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Admission of the main request (Yes)
Admission of a new document (Yes)
Admission of arguments regarding clarity (No)
Admission of arguments regarding inventive step (Yes)
Main request - Inventive step (No) - Catchword
- -
- Citing cases
- T 0781/23
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The patent is revoked.